Canada Approves First Generic Wegovy Alternative Set to Cut WeightLoss Drug Costs

Health Canada has approved the first generic semaglutide, the active ingredient in Wegovy and Ozempic, marking a major shift in weight-loss and diabetes treatment costs across Canada.